(Q37922946)

25 August 2017

1 reference

title

Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls (English)

1 reference

25 August 2017

2

Wilhelm Schänzer

1 reference

25 August 2017

4

Mario Thevis

1 reference

25 August 2017

3

Philippe Delahaut

1 reference

25 August 2017

Andreas Thomas

1

1 reference

25 August 2017

publication date

18 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

56

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

230-235

1 reference

Identification of recombinant equine growth hormone in horse plasma by LC-MS/MS: a confirmatory analysis in doping control

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

High-speed high-performance liquid chromatography of peptides and proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Quantitative detection of trace systemins in Solanaceous plants by immunoaffinity purification combined with liquid chromatography/electrospray quadrupole time-of-flight mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Strategies for determination of insulin with tandem electrospray mass spectrometry: implications for other analyte proteins?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Detection of surreptitious administration of analog insulin to an 8-week-old infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Differentiation and identification of recombinant human erythropoietin and darbepoetin Alfa in equine plasma by LC-MS/MS for doping control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Immuno-based sample preparation for trace analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Doping control analysis of insulin and its analogues in equine plasma by liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Online monitoring of immunoaffinity-based depletion of high-abundance blood proteins by UV spectrophotometry using enhanced green fluorescence protein and FITC-labeled human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Detection of recombinant growth hormone in human plasma by a 2-D PAGE method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

HPLC techniques for proteomics analysis--a short overview of latest developments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Emerging analytical separation techniques with high throughput potential for pharmaceutical analysis, part I: Stationary phase and instrumental developments in LC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Proposal for a common nomenclature for sequence ions in mass spectra of peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Current role of LC-MS(/MS) in doping control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Mass spectrometric determination of insulins and their degradation products in sports drug testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Mass Spectrometric Identification of Degradation Products of Insulin and Its Long-Acting Analogues in Human Urine for Doping Control Purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

An overview of matrix effects in liquid chromatography-mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

Immuno-affinity solid-phase extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2011.08.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2011.08.009

1 reference

25 August 2017

1 reference